HC Wainwright reaffirmed their buy rating on shares of Processa Pharmaceuticals (NASDAQ:PCSA – Free Report) in a report published on Monday morning, Benzinga reports. HC Wainwright currently has a $8.00 price objective on the stock. HC Wainwright also issued estimates for Processa Pharmaceuticals’ Q2 2024 earnings at ($0.98) EPS, Q3 2024 earnings at ($1.02) EPS, […]
Equities Analysts Set Expectations for Processa Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:PCSA) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
76,865 Shares in Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Bought by Spinnaker Trust themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) are set to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Performance NASDAQ […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 303,000 shares, a decrease of 17.6% from the November 30th total of 367,800 shares. Based on an average daily volume of 2,400,000 shares, […]